Page 74 - Read Online

Singh et al. Vessel Plus 2018;2:10 I http://dx.doi.org/10.20517/2574-1209.2018.18 Page 5 of 5

In conclusion, durable bioprosthetic valves can be safely used in patients with contraindications to lifelong
anticoagulation. Further studies are needed to evaluate its long-term efficacy. With advances made in
transcatheter valve insertions, this may be a viable option for younger patients in the near future.

DECLARATIONS
Authors’ contributions
Performed the operation: Beattie G, Curry P
Performed the transoesophageal echocardiography on the patient: Reid D
Wrote the case report, reviewed and made changes to the structure and format of the manuscript: Singh SSA
Served as the primary supervisor of the manuscript: Curry P

Financial support and sponsorship
None.

Conflicts of interest
The authors do not have any conflicts of interest to declare.

Patient consent
Patient consent (images/case history) was obtained during the consent process.

Ethics approval
The study was approved by the local Clinical Governance Unit after consulting the Local Valve
Multidisciplinary Team.

Copyright
© The Author(s) 2018.

REFERENCES

1. Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med 2013;368:1425-33.
2. Liao K, Seifter E, Hoffman D, Yellin EL, Frater RW. Bovine pericardium versus porcine aortic valve: comparison of tissue biological
properties as prosthetic valves. Artif Organs 1992;16:361-5.
3. Carpentier A, Nashef A, Carpentier S, Ahmed A, Goussef N. Techniques for prevention of calcification of valvular bioprostheses.
Circulation 1984;70:165-8.
4. Bartuś K, Litwinowicz R, Kuśmierczyk M, Bilewska A, Bochenek M, Stąpór M, Woźniak S, Różański J, Sadowski J, Kapelak B.
Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year
outcomes. Kardiol Pol 2018;76:618-24.
5. Flameng W, Hermans H, Verbeken E, Meuris B. A randomized assessment of an advanced tissue preservation technology in the juvenile
sheep model. J Thorac Cardiovasc Surg 2015;149:340-5.
6. Puskas JD, Bavaria JE, Svensson LG, Blackstone EH, Griffith B, Gammie JS, Heimansohn DA, Sadowski J, Bartus K, Johnston DR,
Rozanski J, Rosengart T, Girardi LN, Klodell CT, Mumtaz MA, Takayama H, Halkos M, Starnes V, Boateng P, Timek TA, Ryan W,
Omer S, Smith CR; COMMENCE Trial Investigators. The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with
RESILIA tissue. Eur J Cardiothorac Surg 2017;52:432-9.
7. Paradise HT, Berlowitz DR, Ozonoff A, Miller DR, Hylek EM, Ash AS, Jasuja GK, Zhao S, Reisman JI, Rose AJ. Outcomes of
anticoagulation therapy in patients with mental health conditions. J Gen Intern Med 2014;29:855-61.
8. Koertke H, Hoffmann-Koch A, Boethig D, Minami K, Breymann T, El-Arousy M, Seifert D, Koerfer R. Does the noise of mechanical
heart valve prostheses affect quality of life as measured by the SF-36® questionnaire? Eur J Cardiothorac Surg 2003;24:52-7;
discussion 57-8.
9. Hata R, Kurata S, Shinkai H. Existence of malfunctioning proα2(I) collagen genes in a patient with a proα2(I)-chain-defective variant of
Ehlers-Danlos syndrome. Eur J Biochem 1988;174:231-7.
10. McGhie D, Hutchison JG, Nye F, Ball AP. Infective endocarditis caused by Streptococcus mutans. Br Heart J 1977;39:456-8.
11. Weinstein AJ, Moellering RC Jr. Penicillin and gentamicin therapy for enterococcal infections. JAMA 1973;223:1030-2.